{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Northridge",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "87476",
      "recalling_firm": "Medtronic Inc.",
      "address_1": "18000 Devonshire St",
      "address_2": "N/A",
      "postal_code": "91325-1219",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Worldwide distribution.",
      "recall_number": "Z-1613-2021",
      "product_description": "Medtronic REF: MMT-7020D2 Guardian Sensor (3)  for the following packaging:     GS3 1PK 9L OUS2/ GTIN:\t00763000243357  GS3 1PK 9L OUS2/ GTIN:\t00763000318871  Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes.    *Product not distributed within US.",
      "product_quantity": "15,162 units",
      "reason_for_recall": "Use of the continuous glucose monitoring system while actively taking   hydroxyurea, an anti-neoplastic drug  could result in inaccurate elevated sensor glucose readings.",
      "recall_initiation_date": "20210226",
      "center_classification_date": "20210517",
      "report_date": "20210526",
      "code_info": "All Lot numbers within active shelf life"
    }
  ]
}